Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer

• Yu-Ching Wen,
• Van Thi Ngoc Tram,
• Wei-Hao Chen,
• Chien-Hsiu Li,
• Hsiu-Lien Yeh,
• Phan Vu Thuy Dung,
• Kuo-Ching Jiang,
• Han-Ru Li,
• Jiaoti Huang,
• Michael Hsiao,
• Wei-Yu Chen,
• Yen-Nien Liu

Affiliations

Yu-Ching Wen

Department of Urology, Wan Fang Hospital, Taipei Medical University

Van Thi Ngoc Tram

International PhD Program in Medicine, College of Medicine, Taipei Medical University

Wei-Hao Chen

Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University

Chien-Hsiu Li

Genomics Research Center, Academia Sinica

Hsiu-Lien Yeh

Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University

Phan Vu Thuy Dung

Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University

Kuo-Ching Jiang

Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University

Han-Ru Li

Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University

Jiaoti Huang

Department of Pathology, Duke University Medical Center

Michael Hsiao

Genomics Research Center, Academia Sinica

Wei-Yu Chen

Department of Pathology, Wan Fang Hospital, Taipei Medical University

Yen-Nien Liu

Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University